SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000889812-97-000485
Filing Date
1997-02-14
Accepted
1997-02-14 00:00:00
Documents
1
Group Members
ANTHONY B. EVNINANTHONY SUNDAVID R. HATHAWAYKIMBERLEY A. RUMMELSBURGPATRICK F. LATTERELLPETER O. CRISPRAY A. ROTHROCKTED H. MCCOURTNEYVENROCK ASSOCIATESVENROCK ASSOCIATES II, L.P.
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 AMEND. NO. 2 TO STATEMENT OF BENEFICIAL OWNERSHIP SC 13G/A 31863
  Complete submission text file 0000889812-97-000485.txt   34281
Mailing Address 385 OYSTER POINT BLVD SUITE 3 SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BLVD SUITE 3 SOUTH SAN FRANCISCO CA 94080 4157378600
ARRIS PHARMACEUTICAL CORP/DE/ (Subject) CIK: 0000913056 (see all company filings)

IRS No.: 222969941 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44967 | Film No.: 97536293
SIC: 2834 Pharmaceutical Preparations

Mailing Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112 2126495600
VENROCK ASSOCIATES (Filed by) CIK: 0000937889 (see all company filings)

IRS No.: 136300995 | State of Incorp.: NY | Fiscal Year End: 1231